EUCTR2016-002552-24-FR进行中（未招募）1 期
Pemetrexed (Alimta®) in maintenance in patients with impaired renal function: multicenter randomized Phase 4 study comparing two strategies for dose calculation - PKAPIR
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patient over 18 years
- •patient with a non-small cell lung cancer predominantly non-squamous histologically documented
- •Patient planned to start a treatment or ongoing maintenance treatment with pemetrexed
- •Neutrophils> 1500 / mm3; platelets> 100,000 / mm3
- •Written informed consent signed and dated
- •For patients of childbearing age, effective contraception
- •Creatinine clearance according to Cockcroft-Gault formula between 70 and 45 mL / min
- •PS=0 or 1
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patient contraindicated with pemetrexed treatment
- •Patient with symptomatic brain metastases
- •Pregnant or nursing women
- •Patient under guardianship or submitted to major people protection regime
- •Patient not affiliated with a social security scheme (beneficiary or beneficiary)
研究者
相似试验
进行中（未招募）
1 期
Phase 2 trial of pemetrexed (Alimta™) combined with paclitaxel in patients with recurrent/advanced follicular, papillary or anaplastic thyroid cancer - PANTHERAEUCTR2008-001032-12-DEniversitätsklinikum Schleswig-Holstein47
已完成
不适用
The combination therapy of pemetrexed and continued EGFR-TKIs beyond disease progression to first-line EGFR-TKIs treatments in elderly patients with advanced non-small-cell lung cancer harboring EGFR mutations: a phase 2 trial.non-small-cell lung cancerJPRN-UMIN000010935Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine22
已完成
2 期
A Phase 2 Study of Pemetrexed in Patients with Previously Treated Non-Squamous Non-Small-Cell Lung CancerJPRN-UMIN000002467Kobe Lung Cancer Study Group45
招募中
不适用
Study of pemetrexed in previously-treated patients with advanced squamous cell lung carcinoma having low level of TSKCT0003518CC Hospital32
招募中
2 期
Individualized pemetrexed dosing in patients with non-small cell lung cancer or mesothelioma based on renal function to improve treatment response - The IMPROVE-I, -II and -III studieslung cancerNL-OMON54624Radboud Universitair Medisch Centrum100